The technology is composed of 64 threads thinner than a hair, implanted about 2 mm deep into the motor cortex, that control movement intention, with the assistance of a Neuralink surgical robot. The device communicates with the user app via Bluetooth, translating your thoughts into actions, such as making calls or gaming, just by thinking about an associated movement. According to Neuralink’s engineers, this first implant has provided invaluable feedback for further device improvements. The PRIME (Precise Robotically implanted Brain-Computer Interface) clinical trial is designed to last for 6 years with plans to enroll 11 patients in 2024 with an expected exponential growth of 22,204 patients in 2030. While currently focused on enhancing the quality of life for individuals with specific conditions (such as quadriplegia, paraplegia, visual impairment, inability to speak or hear, and/or major limb amputation); one can’t help but wonder: how far will this technology ultimately lead us?